OOIR: Observatory of International Research

Papers

(The H4-Index of Expert Review of Neurotherapeutics is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
An overview of the differences in the pharmacological management of post-traumatic stress disorder between women and men	56
The relevance of cortical thickness in migraine sufferers and implications to therapy	50
Steps to manage treatment-refractory migraine in adults	47
The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives	35
Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington’s disease	34
How have the recent updated epilepsy classifications impacted on diagnosis and treatment?	34
The latest developments with internet-based psychological treatments for depression	33
Laser interstitial thermal therapy for recurrent brain metastases following stereotactic radiosurgery: a systematic review	32
The role of Fecal Microbiota Transplantation (FMT) in treating patients with multiple sclerosis	32
The influence of anxiety and depression on headache in adolescent migraineurs: a case-control study	32
Neuroprotective strategies in multiple sclerosis: a status update and emerging paradigms	31
Where Art Thou O treatment for diabetic neuropathy: the sequel	31
Does electrical stimulation still have a place in the treatment armamentarium for Bell’s palsy?	30
Advances in the treatment and management of frontotemporal dementia	29
Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents	28
New and emerging pharmacotherapeutic options for the treatment of lennox-gastaut syndrome: moving forward in 2025	28
Managing antipsychotic-related sexual dysfunction in patients with schizophrenia	27
Acute and long-term cognitive impairment following sepsis: mechanism and prevention	26
The value and risks of antidepressant therapy in Alzheimer’s disease: a field update and its clinical implications	26
Clinical Insights and Strategies to Managing Depression Subtypes Associated with Tobacco dependence: A Response to the Letter to the Editor	25
Why is ADHD so difficult to diagnose in older adults?	25
Hesitancies in primary headaches treatments	25
Uncertainties in anti-amyloid monoclonal antibody therapy for Alzheimer’s disease: the challenges ahead	25
An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms	24